Your Messages Inbox (0) 
Your Unread Messages
See AllMost Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Top Ten Searches
post partum incontinence fibroid hpv colpotomy ovarian cyst curettage endometriosis intrauterine umbilical cordYour Article Summary
Zoledronic Acid for the Prevention of Bone Loss in Postmenopausal Women With Low Bone Mass: A Randomized Controlled Trial
Obstetrics and Gynecology, 10/27/09
McClung M et al. – Both once–yearly dosing and a single dose of intravenous zoledronic acid 5 mg prevented bone loss for 2 years and were well–tolerated in postmenopausal women with low bone mass.
Related Articles
Intensity and timing of physical activity in relation to postmenopausal breast cancer risk: the prospective NIH-AARP Diet and Health Study
BMC Cancer, 10/05/09
Relevance Score: 90%
Lasofoxifene for the prevention and treatment of postmenopausal osteoporosis
Therapeutics and Clinical Risk Management, 10/16/09
Relevance Score: 89%
Oestrogen plus progestin and lung cancer in postmenopausal women (Womens Health Initiative trial): a post-hoc analysis of a randomised controlled trial
The Lancet, 10/12/09
Relevance Score: 89%
Colorectal cancer incidence and postmenopausal hormone use by type, recency, and duration in cancer prevention study II
Cancer Epidemiology, Biomarkers & Prevention, 10/28/09
Relevance Score: 88%
Testosterone and biological characteristics of breast cancers in postmenopausal women
Cancer Epidemiology, Biomarkers & Prevention, 10/28/09
Relevance Score: 88%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
First-trimester use of paroxetine and congenital heart defects: A population-based case-control study
Birth Defects Research, 11/24/09
Suppression of follicular rupture with meloxicam, a cyclooxygenase-2 inhibitor: potential for emergency contraception
Human Reproduction, 11/24/09
The rationale for mTOR inhibition in epithelial ovarian cancer
Expert Opinion on Investigational Drugs, 11/24/09
Today in Menopausal Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Urinary incontinence and waist circumference in older women
Age and Aging, 11/20/09
Effects of menopausal hormone therapy on hemostatic parameters, blood pressure, and body weight: Open-label comparison of randomized treatment with estradiol plus drospirenone versus estradiol plus norethisterone acetate
European Journal of Obstetrics & Gynecology and Reproductive Biology , 11/20/09
Testosterone addition to estrogen therapy - Effects on inflammatory markers for cardiovascular disease
Gynecological Endocrinology, 11/20/09
Today in Repro Endo - Infertility...keeping you current
Receive free subspecialty "5-minute updates" via email
How common is polycystic ovary syndrome in recurrent miscarriage
Reproductive BioMedicine Online, 11/24/09
Adipose tissue, metabolic syndrome and polycystic ovary syndrome: from pathophysiology to treatment
Reproductive BioMedicine Online, 11/24/09
Chlamydia antibodies and self-reported symptoms of oligoamenorrhea and hirsutism: A new etiologic factor in polycystic ovary syndrome
Fertility and Sterility, 11/24/09
Sponsor
Article Search
Sponsor